BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2010
View Archived Issues
Clinical data from the evaluation of Debio-025 in HCV-infected patients disclosed
Read More
Recent data support safety and potentcy of HCV NS3 protease inhibitor ACH-1625
Read More
Positive modulators of nAChRalpha7 identified at NeuroSearch
Read More
Roche claims novel gamma-secretase inhibitors
Read More
Snapshots: new reports on biomarkers related to cardiovascular disorders
Read More
Novel tachykinin NK3 receptor antagonists identified at Roche
Read More
Tibotek discloses novel CYP450 inhibitors as boosters for anti-HIV agents
Read More
Novel protein kinase inhibitors presented by Priaxon
Read More
Secreted phospholipase A2 a potential marker of traumatic brain injury
Read More
Intraprostatic botulinum toxin type A improves signs and symptoms of BPH
Read More
Padeliporfin-mediated vascular targeted phototherapy promising in prostate cancer trial
Read More
REDUCE study clarifies effects of dutasteride in prostate cancer
Read More
First quarter events at Chugai
Read More
VaxInnate presents preliminary results from phase II study of VAX-125 flu vaccine
Read More
FDA approves once-daily dosing of Kaletra for previously treated HIV patients
Read More
Prana releases position statement on PBT-2 therapeutic strategy in Alzheimer's disease
Read More
Tarceva receives E.U. approval as maintenance treatment in advanced NSCLC
Read More
Takeda submits NDA for azilsartan medoxomil to treat hypertension in the U.S.
Read More
New biotechnology company, Immunovo, secures seed funding
Read More
New company LipimetiX created to focus on lipid-lowering treatments
Read More
FDA issues complete response letter for Giazo NDA
Read More
PolyMedix initiates phase Ib/II dose-ranging PMX-60056 study
Read More
Ceregene starts new phase I/II study of CERE-120 for Parkinson's disease
Read More
Johns Hopkins and the New York Stem Cell Foundation to collaborate on stem cell research
Read More
Dendreon receives FDA approval for Provenge for castrate-resistant prostate cancer
Read More
NexMed's NexACT technology improves delivery and activity of Angstrom's A6 anticancer compound
Read More
Hana Biosciences completes pre-NDA meeting with FDA for Marqibo
Read More